Business Description
Curanex Pharmaceuticals Inc. is a New York-based company focused on turning plant-derived compounds into medicines for people living with inflammatory conditions. Its lead product, Phyto-N, is being studied across a broad range of illnesses, including ulcerative colitis, eczema, gout, diabetes, fatty liver disease, and COVID-19. Founded in 1996 and operating under its current name since late 2023, the company is working to bring natural ingredient-based treatments from early research through to market availability.
